Cargando…

A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis

Detalles Bibliográficos
Autores principales:	Cai, Lin, Zhao, Yan, Zheng, Min, Zhang, Furen, Sun, Qing, Liu, Quanzhong, Hu, Jin, Shen, Juan, Zhang, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106160/ https://www.ncbi.nlm.nih.gov/pubmed/36808115 http://dx.doi.org/10.1097/CM9.0000000000002489

Ejemplares similares

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
por: Cai, Lin, et al.
Publicado: (2020)

Lack of Association between CARD11 and Atopic Dermatitis in Chinese Population
por: Shi, Wenhao, et al.
Publicado: (2022)

Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial
por: Yang, Hyeon-Jong, et al.
Publicado: (2014)

Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial
por: Hsiao, Yun-Hsia, et al.
Publicado: (2016)

Efficacy of Probiotics in Children and Adolescents With Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Study
por: de Andrade, Paula Danielle Santa Maria Albuquerque, et al.
Publicado: (2022)

Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis
por: Li, Yanyan, et al.
Publicado: (2023)

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study
por: Zhao, Y., et al.
Publicado: (2021)

Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
por: Tyring, Stephen K., et al.
Publicado: (2023)

Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
por: Hensel, Patrick, et al.
Publicado: (2015)

SCORAD Reflects the Duration of Atopic Dermatitis Lesions
por: Čelakovská, Jarmila, et al.
Publicado: (2013)

Association of Pityriasis Alba with Atopic Dermatitis: A Cross-Sectional Study
por: Gawai, Sonali Ramkrishna, et al.
Publicado: (2021)

Classification of atopic dermatitis phenotypes according to allergic sensitization by cluster analysis
por: Yum, Hye Yung, et al.
Publicado: (2022)

Hwangryunhaedoktang in adult patients with Atopic Dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial - study protocol
por: Kim, Nam-Kwen, et al.
Publicado: (2011)

KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial – study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2013)

Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
por: Fujishima, Chieko, et al.
Publicado: (2022)

Disseminated life-threatening viral skin rash in a child with atopic dermatitis
por: Herzum, Astrid, et al.
Publicado: (2023)

Thalidomide Responsive Recalcitrant Adult-Onset Atopic Dermatitis – Repurposing an Old Drug
por: Yadav, Vidya, et al.
Publicado: (2023)

Allergy to Soy in an Adolescent Suffering from Atopic Dermatitis
por: Čelakovská, Jarmila, et al.
Publicado: (2013)

Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and phase III trials
por: Simpson, Eric L., et al.
Publicado: (2022)

Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study
por: Chung, Bo Young, et al.
Publicado: (2018)

The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial
por: Li, Ya-qin, et al.
Publicado: (2022)

Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
por: Bakker, D.S., et al.
Publicado: (2019)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

The need of an updated culture of “occupational” atopic hand dermatitis in children at the time of COVID-19
por: Pecoraro, Luca, et al.
Publicado: (2022)

Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
por: Lee, Ju Hyun, et al.
Publicado: (2020)

Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis
por: de Santiago, Miguel Sánchez, et al.
Publicado: (2021)

Food Hypersensitivity in Patients Suffering from Atopic Dermatitis and Sensitization to Soy
por: Čelakovská, J, et al.
Publicado: (2014)

Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders: Study protocol for a double-blind, randomized, and placebo-controlled clinical trial
por: Kang, Su-Jin, et al.
Publicado: (2019)

Randomised, Placebo-Controlled, Double-Blind Study of Oral Tranexamic Acid in the Treatment of Moderate-to-Severe Melasma in an Australian Cohort
por: Bala, Harini Rajgopal, et al.
Publicado: (2022)

Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children
por: Tan, Hsiewe Ying, et al.
Publicado: (2013)

Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)
por: Olivry, Thierry, et al.
Publicado: (2015)

Gene expression profiles of peripheral blood mononuclear cells from patients with atopic dermatitis stimulated with Malassezia globosa
por: Lu, Mao, et al.
Publicado: (2021)

Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial
por: Kang, Su-Jin, et al.
Publicado: (2020)

Efficacy and Safety of Fig (Ficus carica L.) Leaf Tea in Adults with Mild Atopic Dermatitis: A Double-Blind, Randomized, Placebo-Controlled Preliminary Trial
por: Abe, Tatsuya, et al.
Publicado: (2022)

A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean Children
por: Jeon, You Hoon, et al.
Publicado: (2016)

Double-blind controlled randomised study of lactulose and lignin hydrolysed combination in complex therapy of atopic dermatitis
por: Perlamutrov, Yuri N., et al.
Publicado: (2016)

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis
por: Liu, Ping, et al.
Publicado: (2016)

A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19
por: Wagener, Gebhard, et al.
Publicado: (2022)

A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis
por: Liu, Mingsheng, et al.
Publicado: (2023)

Treatment with Methotrexate in Infants and Toddlers with Atopic Dermatitis: A Retrospective Multi-Center Study
por: Barak Levitt, Jen A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5t6p2p1bu0cpdm0s7lvlc0maaj